Study on Chromosome Karyotype and Its Clinical Significance in 281 Cases of Myelodysplastic Syndromes
10.3969/j.issn.1671-7414.2015.04.025
- VernacularTitle:281例骨髓增生异常综合征患者染色体核型分析及临床意义的研究
- Author:
Xiurui HAN
;
Didi YANG
;
Yuan ZHAO
;
Lijie ZHANG
;
Yanchun LI
;
Jiuju WANG
;
Xinhui ZHAI
;
Xucang WEI
;
Jiachen ZHOU
- Publication Type:Journal Article
- Keywords:
myelodysplastic syndrome;
chromosome karyotype;
cytogenetics
- From:
Journal of Modern Laboratory Medicine
2015;(4):91-92,95
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the abnormal karyotype characteristics of myelodysplastic syndrome (MDS)patients and their correlation with clinical prognosis.Methods Analyzed the karyotypes of 281 MDS patients by use of G-banding tech-nique.Results Through analysis of the karyotypes of 281 MDS patients,found that the percentage of abnormal karyotypes was 48.75% (137/281),among 137 patients with abnormal karyotypes,43.07% (59 cases)presented with numerical aber-ration,31.39% (43 cases)with structural aberration,and 25.54% (35 cases)with both numerical and structural abnormali-ties.As for MDS subtypes,the occurrence rate of abnormal karyotype was 63.41% (26/41)in RAEB-2,58.73% (37/63)in RAEB-1,39.2% (49/125)in RCMD,15.38% (2/13)in RAS and 22.58% (7/31)in RA.The rates of abnormal karyotype in RAEB-1 and RAEB-2 were significantly higher than that in RA and RAS(P<0.01),and in RCMD (P <0.05).The fre-quent abnormal karyotypes were as follows:+8,-7/7q-,-20/20q-,complex karyotypes chromosomal translocation,i(17),-Y and +21.The follow-up study of 159 MDS patients indicated that the median survival time was 39 months for 68 patients with normal karyotypes and 21 months for 91 patients with abnormal karyotypes,the former was significantly prolonged than the latter (P < 0.05).As far as the leukemia transition rate was concerned,the patients with aberrant karyotypes (35.5%)were significantly higher than that with normal karyotypes (10.3%)(P < 0.01),among them,the cases with complex karyotypes and-7/7q-more easily transit into leukemia.Conclusion MDS was one kind of clonal hematological ma-lignancy with high heterogeneity.Chromosomal karyotype test plays an important role in the correct diagnosis,typing and prognosis evaluation of MDS.
